Hypertension Control Status and Influencing Factors in Representative Areas of Western China during the Comprehensive Reform of Primary Care System　#br#

doi:10.12114/j.issn.1007-9572.2018.22.016

Abstract

Abstract: Objective　To explore the hypertension control status and influencing factors in representative areas of western China during the comprehensive reform of primary care system.Methods　The data were obtained from the Inhabitants' Family Health Survey，which was carried out by the National Health and Family Planning Commission of the People's Republic of China and Ministry of Finance of the People's Republic of China in 34 key representative areas across 17 provinces from 2014 to 2016 during the comprehensive reform of primary care system.2 269 hypertensive patients from 8 of these areas in western China（Chengbei District and Huangzhong County of Xining City，Hongshan District and Hexigten Banner of Chifeng City，Wuhou District and Xinjin County of Chengdu City，Wudang District and Kaiyang County of Guiyang City） were enrolled.Information regarding sociodemographic characteristics，availability and utilization of medical care，awareness of hypertension management，health behaviors and hypertension control status of the participants was analyzed.And the influencing factors of hypertension control were investigated by multiple Logistic regression analysis.Results　The overall hypertension control rate was 75.23%（1 707/2 269）．Urban areas owned a higher hypertension control rate than rural areas〔84.60%（961/1 136） vs 65.84%（746/1 133）〕（P<0.05）．The hypertension control rate was 60.72%（286/471），71.48%（579/810），93.58%（525/561），74.24%（317/427） for Xining City，Chifeng City，Chengdu City，and Guiyang City，respectively，with significant differences（P<0.05）．Multiple Logistic regression analysis showed that administrative city，urban-rural location，level of household income，awareness level of hypertension，lifestyle，status of hypertension management and medication use were the influencing factors of hypertension control（P<0.05）．Conclusion　The hypertension control in the representative areas of western China was satisfactory，which was associated with administrative city，urban-rural location，level of household income，awareness level of hypertension，lifestyle，status of hypertension management and medication use.It could be further improved by narrowing the income gap between urban and rural areas and between the administrative cities，targeted hypertension education，developing a healthy lifestyle with guidance and enhancing the medication adherence.

Key words: Hypertension；Blood pressure control；Root cause analysis；China, western

摘要：

我国西部典型地区高血压患者血压控制现状及影响因素研究
苑广磊1，秦江梅2*，刘军3*，林春梅2，张丽芳2，张艳春2
目的　了解我国西部典型地区高血压患者的血压控制现状，并探讨影响患者血压控制效果的因素。方法　在国家卫生计生委和财政部于2014—2016年对全国17个省34个基层卫生综合改革重点联系点开展的“居民家庭健康询问调查”数据中，选取西宁市城北区和湟中县、赤峰市红山区和克什克腾旗、成都市武侯区和新津县、贵阳市乌当区和开阳县8个西部重点联系点的2 269例高血压患者的资料进行分析，主要包括人口基本情况、医疗服务可及性和利用情况、对高血压管理的认知、健康行为及血压控制情况等。采用多元Logistic回归分析探讨高血压患者血压控制效果的影响因素。结果　高血压患者的血压控制率为75.23%（1 707/2 269），城市地区（84.60%，961/1 136）高于农村地区（65.84%，746/1 133），差异有统计学意义（P<0.05）。西宁市、赤峰市、成都市、贵阳市高血压患者的血压控制率分别为60.72%（286/471）、71.48%（579/810）、93.58%（525/561）、74.24%（317/427），各地区间差异有统计学意义（P<0.05）。多元Logistic回归分析结果显示，地区、城乡类型、家庭收入水平、高血压知识知晓情况、生活方式、接受高血压健康管理情况、药物使用情况是高血压患者血压控制效果的影响因素（P<0.05）。结论　西部典型地区高血压患者的血压控制现状较好，患者的血压控制效果受地区、城乡类型、家庭收入水平、高血压知识知晓情况、生活方式、接受高血压健康管理情况、药物使用情况等因素的影响。建议缩小各地区、城乡间的收入差距，开展高血压患者的针对性健康教育，引导居民养成健康生活方式，提高患者规律服药依从性。

关键词: 高血压；血压控制；影响因素分析；中国, 西部

YUAN Guang-lei,QIN Jiang-mei,LIU Jun, et al. Hypertension Control Status and Influencing Factors in Representative Areas of Western China during the Comprehensive Reform of Primary Care System　#br#[J]. Chinese General Practice, 2018, 21(22): 2724-2728. DOI: 10.12114/j.issn.1007-9572.2018.22.016.
苑广磊,秦江梅,刘军等. 我国西部典型地区高血压患者血压控制现状及影响因素研究[J]. 中国全科医学, 2018, 21(22): 2724-2728. DOI: 10.12114/j.issn.1007-9572.2018.22.016.

[1]	LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740.
[2]	CUI Yiyuan, YAN Yijing, WANG Ying, MENG Xiangju, ZHANG Qinglin, LIU Lixing, LI Sicong, FENG Li, The Working Group for the Clinical Practice Guideline for the Cancer-related Fatigue with Integrated Traditional Chinese and Western Medicine. Clinical Practice Guideline for the Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Cancer-related Fatigue [J]. Chinese General Practice, 2025, 28(27): 3345-3358.
[3]	ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228.
[4]	NI Minhan, WU Zhihan, ZHOU Siyu, HUANG Xianhong, SUN Tao, WANG Xiaohe, CUI Linlin. Research on the Digital Traditional Chinese and Western Medicine Collaborative Health Governance Model Based on the Logic of Health Co-prosperity [J]. Chinese General Practice, 2025, 28(13): 1567-1572.
[5]	PENG Hongye, LU Chunli. The Current Status and Challenges of Integrative Chinese and Western Medicine in the Treatment and Management of Prediabetes from a Proactive Health Perspective [J]. Chinese General Practice, 2025, 28(13): 1573-1582.
[6]	WANG Yiquan, CHEN Wanjia, LIU Wangyi, ZHANG Luyun, DENG Yueyi. The Prognosis of Stage 4 Chronic Kidney Diseasetreated with Fermented Cordyceps Sinensis Powder: Based on a Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(09): 1084-1091.
[7]	PENG Hongye, JING Yanan, LIU Dianchun, WANG Ying, XUE Xue, LU Chunli. Domestic and International Advances and Challenges in Early Diagnosis of Prediabetes with Integrated Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(03): 262-272.
[8]	WEI Xu, XU Weiguo, LI Luguang, QIN Xiaokuan, GE Long, YANG Kexin, GAO Jinghua, ZHU Liguo. Guidelines for the Diagnosis and Treatment of Lumbar Spinal Stenosis with Integrated Traditional Chinese Medicine and Western Medicine (2023) [J]. Chinese General Practice, 2024, 27(25): 3076-3082.
[9]	ZHANG Lan, ZHANG Ruihua, WU Xuelian, YANG Yan, DUAN Guimin, ZHAO Daren. Equity Analysis and Demand Prediction of General Practitioner Resource Allocation in Western China [J]. Chinese General Practice, 2024, 27(25): 3171-3177.
[10]	GU Shanshan, XU Yun, FU Li, WANG Jinghui, GUO Xingyu. Study on the Traditional Chinese Medicine Syndrome Characteristics of Cancer-related Fatigue and Their Correlation with Thyroid Function Level [J]. Chinese General Practice, 2024, 27(21): 2623-2629.
[11]	JING Tao, DAI Yongmei, LUO Jianying, LUO Wei, JI Yelinfan, PENG Chi, ZHANG Cuijun, CAO Yanjun, ZHENG Qing, HUANG Yu, SHEN Hejun. Research on the Situation Characteristics of Health Literacy and Sedentary Time of High School Students on Both Sides of the "Hu Line" [J]. Chinese General Practice, 2024, 27(18): 2233-2242.
[12]	Expert Consensus Writing Group of Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease. Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition) [J]. Chinese General Practice, 2023, 26(35): 4359-4371.
[13]	LIAN Lu, CHEN Jiaying, WANG Xuanxuan, LI Yahui, ZHU Ya. Current Situation and Countermeasure of Medical Service Capacity of Primary Care Physicians in China [J]. Chinese General Practice, 2023, 26(34): 4246-4253.
[14]	ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832.
[15]	GONG Rui, ZHANG Yue, CHENG Zhixin, TANG Weihe. A Case Report of Venous Thromboembolism with Heparin-induced Thrombocytopenia Characterized by Venous Limb Gangrene Treated with Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2023, 26(06): 769-774.